Hinge Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Daniel A. Perez
- Full Time Employees
- 1,514
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 455 Market Street San Francisco CA United States of America 94105
- IPO Date
- May 22, 2025
- CIK
- 0001673743
- Website
- hingehealth.com
- Similar Companies
- Business
- Hinge Health, Inc. Hinge Health, Inc. (NYSE: HNGE) provides a digital platform delivering musculoskeletal (MSK) care through virtual physical therapy, AI-powered technologies, wearable devices, and clinician support services; core offerings include the Enso wearable for motion tracking and feedback, TrueMotion computer vision for exercise form correction, personalized exercise therapy programs, behavioral health coaching, patient education content, and specialized pelvic health programs for women; the platform addresses acute injuries, chronic pain, post-surgical rehabilitation, and joint/muscle conditions to reduce surgeries, opioid use, and healthcare costs for employers, health plans, and over 1 million members across more than 2,250 clients including nearly half of the Fortune 100. Founded in 2014 by Daniel Perez and Gabriel Mecklenburg and headquartered at 455 Market Street in San Francisco, California, the company operates primarily in the United States with expansion into Canada in 2024 and planned entry into Europe in 2025; it serves self-insured employers, national/regional health plans, and pharmacy benefit managers through its AI-driven HingeConnect database that identifies high-risk patients and optimizes care delivery. In May 2025, Hinge Health completed its initial public offering on the NYSE, raising approximately $437 million by selling 9.14 million shares at $32 each, opening at $39.25 and closing at $37.56 to mark a successful public market debut following prior private rounds including $400 million Series E in 2021; the company reported 53% year-over-year revenue growth to $154 million in Q3 2025 while advancing AI-enabled features that reduce physical therapy care hours by 95% and enhance member adherence and outcomes.
NYSE Content Update: Hinge Health Shares Up 72% One Year from its IPO
Oura's IPO Could Reveal Whether Wellness Tech Is Finally Wall Street-Ready
Does Hinge Health Inc. (HNGE) Have the Potential to Rally 25.14% as Wall Street Analysts Expect?
Surging Earnings Estimates Signal Upside for Hinge Health Inc. (HNGE) Stock
Hinge Health Q1 Earnings Call Highlights
HNGE Stock Up on Q1 Earnings & Revenue Beat, 2026 Outlook Improved
Hinge Health, Inc. (HNGE) Q1 2026 Earnings Call Transcript
Hinge Health reports record first quarter 2026 financial results
Hinge Health launches comprehensive Migraine Care Program
Analyzing Hinge Health (NYSE:HNGE) and 10x Genomics (NASDAQ:TXG)
Director Sells 50,000 Shares of Digital Health Platform Stock for $1.9 Million, According to Recent SEC Filing
Hinge Health (NYSE:HNGE) Chairman Gabriel M.I. Mecklenburg Sells 50,000 Shares of Stock
Hinge Health to announce first quarter 2026 financial results on May 5, 2026
Here's Why You Should Add Hinge Health Stock to Your Portfolio Now
Hinge Health now supports over 300 public sector organizations including 24 state governments
James Budge Sells 11,006 Shares of Hinge Health (NYSE:HNGE) Stock
James Pursley Sells 15,000 Shares of Hinge Health (NYSE:HNGE) Stock
Hinge Health (NYSE:HNGE) versus HeartSciences (NASDAQ:HSCS) Financial Analysis
Brokerages Set Hinge Health Inc. (NYSE:HNGE) Target Price at $57.07
Hinge Health appoints Tyler Sloat to its board of directors